{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:03:08Z","timestamp":1747206188716,"version":"3.40.5"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HMER"],"DOI":"10.2147\/hmer.s189158","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T21:16:22Z","timestamp":1550006182000},"page":"35-40","source":"Crossref","is-referenced-by-count":0,"title":["<p>Ombitasvir, paritaprevir, and ritonavir with peginterferon-α2a plus ribavirin in treatment-experienced patients with chronic hepatitis C virus genotype 1 infection<\/p>"],"prefix":"10.2147","volume":"Volume 11","author":[{"given":"David","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7911-227X","authenticated-orcid":true,"given":"Daniel E","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,2]]},"container-title":["Hepatic Medicine: Evidence and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=48010","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=48010","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T21:16:23Z","timestamp":1550006183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/ombitasvir-paritaprevir-and-ritonavir-with-peginterferon-alpha2a-plus--peer-reviewed-article-HMER"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/hmer.s189158","relation":{},"ISSN":["1179-1535"],"issn-type":[{"type":"electronic","value":"1179-1535"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}